Literature DB >> 22203183

Does the final intraoperative PTH level really have to fall into the normal range to signify cure?

Alexandra E Reiher1, Sarah Schaefer, Herbert Chen, Rebecca S Sippel.   

Abstract

BACKGROUND: Intraoperative parathyroid hormone (IOPTH) helps shorten the duration of surgery and increase the likelihood of surgical cure. Although general consensus agrees that the IOPTH should fall by 50%, there is much debate as to whether the IOPTH needs to fall into the normal range.
METHODS: We retrospectively reviewed a prospective database of patients undergoing surgery for treatment of primary hyperparathyroidism. We included all patients with an IOPTH that fell by >50% by 10 or 15 min, but that did not fall into the normal range (parathyroid hormone remained ≥ 60 pg/ml). We excluded patients who had undergone prior neck surgery or had known multiple endocrine neoplasia 1 or 2.
RESULTS: A total of 1,231 patients underwent a parathyroidectomy, 155 of whom met the study's inclusion/exclusion criteria (12.6%). A total of 117 patients had an IOPTH fall by 50% by 10 min, and 38 patients' IOPTH fell by 50% by 15 min. Overall surgical cure rate was 98.7%. One patient from the 10-minute group and one patient from the 15-minute group had persistent disease on follow-up. One patient in the 15-minute group had recurrent disease. With a mean ± SEM 18.1 ± 2.1 months' follow-up, the recurrence rate in this cohort was 0.6%. The average calcium at last follow-up was 9.4 ± 0.0 mg/dl.
CONCLUSIONS: Allowing the IOPTH to fall by 50% by 15 min, regardless of whether the IOPTH falls into the normal range, results in a high success rate when performed by experienced surgeons. This helps reduce intraoperative time used waiting for additional parathyroid hormone levels and the risks associated with unnecessary bilateral neck exploration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203183     DOI: 10.1245/s10434-011-2192-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  The small abnormal parathyroid gland is increasingly common and heralds operative complexity.

Authors:  Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

2.  The final intraoperative parathyroid hormone level: how low should it go?

Authors:  Laura I Wharry; Linwah Yip; Michaele J Armstrong; Mohamed A Virji; Michael T Stang; Sally E Carty; Kelly L McCoy
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

3.  Risk factors for "PTH spikes" during surgery for primary hyperparathyroidism.

Authors:  Philipp Riss; Christoph Krall; Christian Scheuba; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2013-07-05       Impact factor: 3.445

4.  Evaluation of the 'putative' role of intraoperative intact parathyroid hormone assay during parathyroidectomy for secondary hyperparathyroidism. A retrospective study on 35 consecutive patients: intraoperative iPTH assay during parathyroidectomy.

Authors:  G Conzo; A Perna; N Avenia; R M De Santo; C Della Pietra; A Palazzo; A A Sinisi; F Stanzione; L Santini
Journal:  Endocrine       Date:  2012-03-16       Impact factor: 3.633

5.  Primary hyperparathyroidism after Roux-en-Y gastric bypass.

Authors:  Yufei Chen; Carrie C Lubitz; Scott A Shikora; Richard A Hodin; Randall D Gaz; Francis D Moore; Travis J McKenzie
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

6.  Outcomes after subtotal parathyroidectomy for primary hyperparathyroidism due to hyperplasia: significance of whole vs. partial gland remnant.

Authors:  Mohammad H Rajaei; Sarah C Oltmann; David F Schneider; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2014-09-23       Impact factor: 5.344

7.  Significance of rebounding parathyroid hormone levels during parathyroidectomy.

Authors:  David F Schneider; Kristin A Ojomo; Haggi Mazeh; Sarah C Oltmann; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2013-05-03       Impact factor: 2.192

8.  Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism.

Authors:  Mohammad H Rajaei; Alex M Bentz; David F Schneider; Rebecca S Sippel; Herbert Chen; Sarah C Oltmann
Journal:  Ann Surg Oncol       Date:  2014-09-06       Impact factor: 5.344

9.  Role of intraoperative PTH monitoring and surgical approach in primary hyperparathyroidism.

Authors:  Angela A Khan; Yasmin Khatun; Abigail Walker; Jaime Jimeno; Johnathan G Hubbard
Journal:  Ann Med Surg (Lond)       Date:  2015-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.